Down-regulation of TCF8 is involved in the leukemogenesis of Adult T-cell leukemia lymphoma

Blood

Volumn 112, Issue 2, 2008, Pages 383-393

  Hidaka, Tomonori ^a   Nakahata, Shingo ^a   Hatakeyama, Kinta ^b   Hamasaki, Makoto ^a,c   Yamashita, Kiyoshi ^a   Kohno, Takashi ^d   Arai, Yasuhito ^e   Taki, Tomohiko ^f   Nishida, Kazuhiro ^f   Okayama, Akihiko ^a   Asada, Yujiro ^b   Yamaguchi, Ryoji ^a   Tsubouchi, Hirohito ^a,g   Yokota, Jun ^d   Taniwaki, Masafumi ^f   Higashi, Yujiro ^h   Morishita, Kazuhiro ^a,b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c Miyazaki Prefectural Health Foundation   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e Cancer Genome Project   (United Kingdom)

^f KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^g KAGOSHIMA UNIVERSITY   (Japan)

^h OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 8; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; ZEB1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES FLUID; CANCER INHIBITION; CANCER RESISTANCE; CD4+ T LYMPHOCYTE; CHROMOSOME 10P; CHROMOSOME 14Q; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; LEUKEMIA CELL; LEUKEMOGENESIS; MISSENSE MUTATION; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTRAL KARYOTYPING; SURVIVAL RATE; T CELL LEUKEMIA; T CELL LYMPHOMA; THYMUS; VIRUS CARCINOGENESIS; ANIMAL; CELL CULTURE; CHROMOSOME 10; CHROMOSOME 14; GENETICS; KARYOTYPING; PATHOLOGY; PHYSIOLOGY; T CELL LEUKEMIA LYMPHOMA;

ANIMALS; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 14; DOWN-REGULATION; HOMEODOMAIN PROTEINS; HUMANS; KARYOTYPING; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 47649085691     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-01-131185     Document Type: Article

References (51)

1. Takatsuki K, Yamaguchi K, Kawano F, et al. Clinical diversity in adult T-cell leukemia-lymphoma. Cancer Res. 1985;45:4644s-4645s.
2. Matsuoka M. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene. 2003;22: 5131-5140.
3. Yoshida M. Multiple viral strategies of HTLV-1 tor dysregulation of cell growth control. Annu Rev Immunol. 2001;19:475-496.
4. Tamiya S, Matsuoka M, Etoh K. Two types of detective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood. 1996:88:3065-3073.
5. Koiwa T, Hamano-Usami A, IshidaT 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol. 2002:76:9389-9397.
6. Okamoto T Ohno Y, Tsugane S, et al. Multi-step carcinogenesis model tor adult T-cell leukemia. Jpn J Cancer Res. 1989;80:191-195.
7. Look AT. Oncogenic transcription factors in the human acute leukemias. Science. 1997:278: 1059-1064.
8. Kamada N, Sakurai M, Miyamoto K, et al. Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report. Cancer Res. 1992;52:1481-1493.
9. Tsukasaki K, Krebs J, Nagai K, et al. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood. 2001:97:3875-3881.
10. Oshiro A, Tagawa H. Ohshima K, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood. 2006;107:4500-4507.
11. National Center for Biotechnology Information. GenBank. http://www.ncbi.nlm.nih.gov/site/entrez. Accessed December 12. 2007.
12. Williams TM, Moolten D, Burlein J, et al. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science. 1991;25:1791-1794.
13. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005:132:3151-3161.
14. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial- mesenchymal transitions. Nat Rev Mol Cell Biol. 2006:7:131-142.
15. Sasaki H, Nishikata I, ShiragaT, et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood. 2005;105:1204-1213.
16. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukeamialymphoma: a report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79:428-437.
17. Schneider U, Schwenk HU, Bornkamm G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer. 1977;19: 621-626.
18. Minowada J, Onuma T, Moore GE. Rosetteforming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst. 1972;49:891-895.
19. Yamada Y, Ohmoto Y, Hata T. et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma. 1996;21:443-447.
20. Okada M, Maeda M, Tagaya Y et al. TCGF (IL 2)-receptor induction Factor (S), II: possible role of ATL-derived factor (ADF) on constitutive IL2 receptor expression of HTLV-1 (+) T cell lines. J Immunol. 1985;135:3995-4003.
21. Miyoshi I, Kubonishi L Yoshimoto S, et al. Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukaemic T cells. Nature. 1981;294:770-771.
22. Gillis S, Smith KA. Long term culture of tumourspecific cytotoxic T cells. Nature. 1977;268:154-156.
23. Shaffer LG, Tommerup N (eds). ISCN (2005): An International System for Human Cytogenetic Nomenclature. S. Karger, Basel; 2005.
24. Kakazu N, Taniwaki M, Horiike S, et al. Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome. Gene Chromosome Cancer. 1999:26: 336-345.
25. Taniwaki M, Nishida K, Ueda Y et al. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood. 1995;85:3223-3228.
26. National Center for Biotechnology Information. http://www.ncbi.nlm.nih. gov/project/genome. Accessed December 12,2007.
27. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using highdensity oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005; 65:6071-6079.
28. Higashi Y Moribe H. Takagi T et al. Impairment of T cell development in deltaEF1 mutant mice. J Exp Med. 1997;185:1467-1479.
29. Takagi T Moribe H, Kondoh H, Higashi Y DeltaEF1 . a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development. 1998;125:21-31.
30. Hark AT, Schoenherr CJ, Katz DJ, et al. CTCF mediates methylation-sensitive enhancerblocking activity at the H19/Igf2 locus. Nature. 2000;405:486-489.
31. Bell AC, Felsenfeld G. Methylation of a CTCFdependent boundary controls imprinted expression of the Igf2 gene. Nature. 2000;405:482-485.
32. Schmelz K. Wagner M, Dorken B. Tamm I. 5-Aza2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia. Int J Cancer. 2005;114:683-695.
33. Soengas MS, Capodieci P, Polsky D. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 2001;409:207-211.
34. Licona-Limon P, Soldevila G. The role of TGFbeta superfamily during T cell development: new insights. Immunol Lett. 2007;109:1-12.
35. Niitsu Y, Urushizaki Y, Koshida Y et al. Expression of TGF-beta gene in adult Tcell leukemia. Blood. 1988;71:263-266.
36. Kim SJ, Kehrl JH, Burton J, et al. Trans activation of the transforming growth factor beta 1 (TGFbeta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult Tcell leukemia. J Exp Med. 1990;172:121-129.
37. Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M. Aberrant expression of the M EL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood. 2004;103:2753-2760.
38. Arnulf B, Villemain A, Nicot C, et al. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I. Blood. 2002;100:4129-4138.
39. Xu X, Heidenreich O, Kitajima I, et al. Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis. Oncogene. 1996;13: 135-142.
40. Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFβ/BMP signaling pathway. EMBO J. 2003;22:2443-2452.
41. Postigo AA, Depp JL, Taylor JJ, Kroll KL. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 2003;22:2453-2462.
42. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415-428.
43. Murakami Y Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci. 2005:96:543-552.
44. Yang L, Han Y, Saurez Saiz F, Minden MD. Atumor suppressor and oncogene: the WT1 story. Leukemia. 2007;21:868-876.
45. Dik WA, Pike-Overzet K. Weerkamp F, et al. New insights on human T cell develoment by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med. 2005; 201:1715-1723.
46. Christ M. McCartney-Francis NL, Kulkarni AB, et al. Immune dysregulation in TGF-β1 -deficient mice. J Immunol. 1994;153:1936-1946.
47. Plum J, De Smedt M, Leclercq G, Vandekerckhove B. Influence of TGF-β on murine thymocyte development in fetal thymus organ culture. J Immunol. 1995;154:5789-5798.
48. Postigo AA, Dean DC. Independent repressor domains in ZEB regulate muscle and T-cell differentiation. Mol Cell Biol. 1999;19:7961-7971.
49. Fontemaggi G, Gurtner A, Damalas A, et al. δEF1 repressor controls selectively p53 family members during differentiation. Oncogene. 2005;24: 7273-7280.
50. Chen J, Yusuf I. Andersen HM, Fruman DA. FOXO transcription factors cooperate with δEF1 to activate growth suppressive genes in B lymphocytes. J Immunol. 2006;176:2711-2721.
51. Fukuda R, Hayashi A, Utsunomiya A, et al. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL). Proc Natl Acad Sci U SA. 2005;102:15213-15218.